natgillin/translations-raw huggingface dataset:
Do not give to your newborn baby (up to 4 weeks old), unless recommended by your doctor.
Zdravila ne dajajte svojemu novorojenčku (staremu do 4 tedne), razen če vam tega ne priporoči vaš zdravnik.
• you have had an operation recently on your eyes or brain
• če ste pred kratkim imeli operacijo oči ali možganov
As benzyl alcohol may cross the placenta, it is recommended to use a formulation that does not contain benzyl alcohol.
Ker gre benzilalkohol lahko skozi placento, je priporočljivo uporabiti formulacijo, ki ne vsebuje benzilalkohola.
EXP The contents of the multidose vial should be used within 28 days of opening.
EXP Vsebino večodmerne viale porabite v 28 dneh po odprtju.
This is because they are not exactly the same and do not have the same activity and instructions for use.
Ta zdravila namreč niso povsem enaka ter nimajo enake aktivnosti in navodil za uporabo.
From a microbiological point of view, unless the method of dilution precludes the risk of microbial contamination, the product should be used immediately.
Z mikrobiološkega stališča, razen če metoda redčenja ne izključuje tveganja mikrobne kontaminacije, je treba zdravilo porabiti takoj.
• If you have problems with your kidneys you may be given a smaller amount of Inhixa.
• Če imate težave z ledvicami, boste lahko dobili manjšo količino zdravila Inhixa.
• When you go home, you may need to continue to use Inhixa and give it yourself.
• Ko boste odšli domov, boste morda morali še naprej uporabljati zdravilo Inhixa in si ga boste morali dajati sami.
Inhixa is indicated in adults for:
Zdravilo Inhixa je indicirano pri odraslih za:
If you think that you have used too much or too little Inhixa, tell your doctor, nurse or pharmacist immediately, even if you have no signs of a problem.
Če menite, da ste uporabili preveč ali premalo zdravila Inhixa, nemudoma obvestite svojega zdravnika, medicinsko sestro ali farmacevta, tudi če nimate nobenih težav.
• When you go home, you may need to continue to use Inhixa and give it yourself (see instructions below on how to do this).
• Ko boste odšli domov, boste morda morali še naprej uporabljati zdravilo Inhixa in si ga boste morali dajati sami (glejte spodnja navodila, kako to naredite).
It is important for you to keep having Inhixa injections until your doctor decides to stop them.
Pomembno je, da injekcije zdravila Inhixa uporabljate, dokler vam zdravnik ne naroči, da prenehajte.
- The other ingredients are benzyl alcohol (see section 2) and water for injections.
- Druge sestavine so benzilni alkohol (glejte poglavje 2) in voda za injekcije.
Total VTE
Vse VTE
For storage conditions after first opening and dilution of the medicinal product, see section 6.3.
Za pogoje shranjevanja po prvem odprtju in redčenju zdravila glejte poglavje 6.3.
• if you have a painful rash of dark red spots under the skin which do not go away when you put pressure on them.
• Če imate boleč izpuščaj s temno rdečimi podkožnimi pegami, ki ne izginejo, če nanje pritisnete.
High volumes of medicinal products containing benzyl alcohol should be used with caution and only if necessary in patients with liver or kidney impairment, or in pregnant women, because of the risk of accumulation of benzyl alcohol and its toxicity (metabolic acidosis).
Velike količine zdravil, ki vsebujejo benzilalkohol, je treba previdno in samo po potrebi uporabljati pri bolnikih z okvaro jeter ali ledvic ali pri nosečnicah zaradi tveganja kopičenja benzilalkohola in njegove toksičnosti (metabolična acidoza).
• The maximum amount of Inhixa given for the first two injections is 7,500 IU (75 mg).
• Največji odmerek zdravila Inhixa, uporabljen v prvih dveh injekcijah, je 7.500 i.e. (75 mg).
Subcutaneous, intravenous use.
Subkutana, intravenska uporaba.
Concomitant use with caution
Sočasna uporaba, ki zahteva previdnost
This is because large amounts of benzyl alcohol can build-up in your body and may cause side effects (called “metabolic acidosis”).
Saj se lahko velike količine benzilnega alkohola kopičijo v telesu in lahko povzročijo neželene učinke (imenovane " metabolična acidoza").
Before injecting yourself with Inhixa - Check the expiry date on the medicine.
Preden si injicirate zdravilo Inhixa - Preverite datum izteka roka uporabnosti na ovojnini.
Let go of the plunger and allow the syringe to move up until the entire needle is guarded and locks into place.
9) Izpustite bat in pustite, da se brizga pomakne navzor, dokler celotna igla ni pokrita in se ne zaskoči.
Like other similar medicines (medicines to reduce blood clotting), Inhixa may cause bleeding which may potentially be life-threatening.
Tako kot druga podobna zdravila (zdravila proti strjevanju krvi) lahko tudi zdravilo Inhixa povzroči krvavitve, ki so lahko celo smrtno nevarne.
Benzyl alcohol may also cause toxic reactions in infants and children up to 3 years old, due to increased risk of accumulation.
Benzilalkohol lahko povzroči tudi toksične reakcije pri dojenčkih in otrocih do 3 let, zaradi povečanega tveganja kopičenja.
If you are going to have a spinal puncture or an operation where an epidural or spinal anaesthetic is used, tell your doctor that you are using Inhixa.
Če imate predvideno spinalno punkcijo ali operacijo, pri kateri se uporablja spinalna ali epiduralna anestezija, morate zdravniku povedati, da uporabljate zdravilo Inhixa.
Ask your doctor or pharmacist for advice if you have a liver or kidney disease, or if you are pregnant or breast-feeding.
Posvetujte se z zdravnikom ali s farmacevtom, če imate bolezen jeter ali ledvic ali če ste noseči ali dojite.
Other medicines and Inhixa
Druga zdravila in zdravilo Inhixa
Chemical and physical in-use stability has been demonstrated for 8 hours at 25°C.
Kemijska in fizikalna stabilnost med uporabo je bila dokazana za 8 ur pri temperaturi 25 °C.
• Your doctor will normally ask you to take acetylsalicylic acid as well.
• Praviloma vam bo zdravnik poleg tega predpisal tudi acetilsalicilno kislino.
From a microbiological point of view, once opened, the product may be stored for a maximum of 28 days below 25°C.
Z mikrobiološkega stališča, lahko izdelek po odprtju shranjujete največ 28 dni pod temperaturo 25 °C.
At doses used for treatment
V odmerkih, ki se uporabljajo za zdravljenje
• you are currently using medicines which affect bleeding (see section below - Other medicines).
• če trenutno uporabljate zdravila, ki vplivajo na strjevanje krvi (glejte spodaj - poglavje Druga zdravila).
Inhixa can be used during breastfeeding.
Zdravilo Inhixa se lahko uporablja med obdobjem dojenja.
Changing of anticoagulant treatment
Menjava antikoagulantnih zdravil
The anticoagulant effects can be largely neutralized by the slow intravenous injection of protamine.
Antikoagulantni učinek je mogoče v veliki meri nevtralizirati s počasnim intravenskim injiciranjem protamina.
Do not start treatment with Inhixa until 12 hours after the final dose of direct oral anticoagulant.
Zdravljenja z zdravilom Inhixa ne začnite prej kot 12 ur po zadnjem odmerku neposrednega peroralnega antikoagulansa.
The needle guard, which is in the form of a plastic cylinder, will be activated automatically and it will completely cover the needle.
Varovalo konice, ki je v obliki plastičnega valja, bo avtomatsko zdrsnilo na konico in jo v celoti pokrilo.
OUTER BOX MULTIDOSE VIAL
ZUNANJA ŠKATLA VEČODMERNE VIALE
Do not inject Inhixa into a muscle.
Zdravila Inhixa ne injicirajte v mišico.
Important information about some of the ingredients of Inhixa Inhixa contains benzyl alcohol (45 mg/3 mL; 75 mg/5 mL; 150 mg/10 mL).
Pomembne informacije o nekaterih sestavinah zdravila Inhixa Inhixa vsebuje benzilalkohol (45 mg/3 ml; 75 mg/5 ml; 150 mg/10 ml).
Use in children and adolescents The safety and efficacy of Inhixa has not been evaluated in children or adolescents.
Uporaba pri otrocih in mladostnikih Varnost in učinkovitost zdravila Inhixa pri otrocih in mladostnikih nista bili ocenjeni.
What Inhixa is and what it is used for
Kaj je zdravilo Inhixa in za kaj ga uporabljamo
Chemical and physical in-use stability has been demonstrated for 28 days at 25°C.
Kemijska in fizikalna stabilnost med uporabo je bila dokazana za 28 dni pri temperaturi 25 °C.
- Systemic salicylates, acetylsalicylic acid at anti-inflammatory doses, and NSAIDs including ketorolac,
- sistemski salicilati, acetilsalicilna kislina v protivnetnih odmerkih in NSAID, vključno s ketorolakom,
History of HIT (>100 days)
Anamneza HIT (> 100 dni)
Stop using Inhixa and talk to a doctor or nurse at once if you get any signs of a severe allergic reaction (such as difficulty breathing, swelling of the lips, mouth, throat or eyes).
Nehajte uporabljati zdravilo Inhixa in se takoj posvetujte z zdravnikom ali medicinsko sestro, če se vam pojavi kakršen koli znak hude alergijske reakcije (na primer težko dihanje, oteklost ustnic, ust, žrela ali oči).
• If you have restricted mobility due to illness, you will normally be given 4,000 IU (40 mg) of
• Če imate zaradi bolezni omejeno mobilnost, boste po navadi dobili 4.000 i.e. (40 mg) zdravila
In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded .
Z namenom izboljšanja sledljivosti bioloških zdravil je treba jasno zabeležiti ime in številko serije uporabljenega zdravila.
This helps your body to break them down and stop them causing you harm.
Vašemu telesu pomaga razgraditi strdke, da vas ti ne bodo več ogrožali.
Do not try to inject yourself if you have not been trained how to do so.
Injiciranja ne izvajajte sami, če vas tega ni nihče naučil.
When the container is full, dispose of it as your doctor or pharmacist has instructed.
Ko je zabojnik poln, ga odstranite, kot vam je naročil zdravnik ali farmacevt.
Inhixa can be used for two different types of heart attack called STEMI (ST segment elevation myocardial infarction) or Non STEMI (NSTEMI).
Zdravilo Inhixa se lahko uporablja za dve različni vrsti srčnega infarkta: STEMI (srčni infarkt z dvigom spojnice ST) ali ne-STEMI (NSTEMI).
What you need to know before you use Inhixa
Kaj morate vedeti, preden boste uporabili zdravilo Inhixa
The absolute bioavailability of enoxaparin sodium after subcutaneous injection, based on anti-Xa activity, is close to 100%.
Absolutna biološka uporabnost natrijevega enoksaparinata po subkutani injekciji je na podlagi aktivnosti anti-Xa skoraj 100 %.
This could be a liver problem.
Lahko gre za težave z jetri.
• If you are using Inhixa to treat blood clots in your body and going to receive spinal or epidural anaesthesia or lumbar puncture within 24 hours.
• Če uporabljate Inhixa za zdravljenje krvnih strdkov in imate v 24 urah predvideno spinalno anestezijo, epiduralno anestezijo ali lumbalno punkcijo.
Benzyl alcohol has been linked with the risk of severe side effects including breathing problems (called “gasping syndrome”) in young children.
Benzilalkohol je bil povezan z nevarnostjo hudih neželenih učinkov, vključno z dihalnimi težavami (imenovanimi "sindrom hlastanja za zrakom") pri majhnih otrocih.
Immune system disorders • Common: Allergic reaction
Bolezni imunskega sistema • Pogosti: Alergijska reakcija
• At the same time you will also be given Inhixa as an injection underneath your skin (subcutaneous injection).
• Obenem boste dobili zdravilo Inhixa tudi v injekciji pod kožo (subkutano).
Check the expiry date on the medicine.
- Preverite datum izteka roka uporabnosti na ovojnini.
Elimination appears monophasic with a half-life of about 5 hours after a single subcutaneous dose to about 7 hours after repeated dosing.
Kaže, da je odstranjevanje enofazno; razpolovni čas je od 5 ur po uporabi enkratnega subkutanega odmerka do približno 7 ur po ponavljajočem se odmerjanju.
In some cases it is not possible to achieve an exact dose due to the graduations on the syringe, and in such case the volume shall be rounded up to the nearest graduation.
V nekaterih primerih zaradi graduacije na brizgi ni mogoče nastaviti točnega odmerka; v takšnem primeru je treba količino zaokrožiti na najbližjo graduacijo.
Inhixa multidose vial contains benzyl alcohol and must not be used in newborn and premature neonates (see section 4.3).
Večodmerna viala Inhixa vsebuje benzilalkohol in se ga ne sme uporabljati pri novorojenčkih in prezgodaj rojenih novorojenčkih (glejte poglavje 4.3).
• you have diabetes or problems with blood vessels in the eye caused by diabetes (called diabetic retinopathy)
• če imate sladkorno bolezen ali imate zaradi sladkorne bolezni težave z žilami v očeh (to imenujemo diabetična retinopatija)
Enoxaparin sodium has no or negligible influence on the ability to drive and use machines.
Natrijev enoksaparinat nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
• If you are bleeding heavily or have a condition with a high risk of bleeding (such as stomach ulcer, recent surgery of the brain or eyes), including recent bleeding stroke.
• Če močno krvavite ali imate kakšno motnjo, ki jo spremlja veliko tveganje za krvavitev (npr. razjedo na želodcu, nedavno operacijo na možganih ali očeh), vključno z nedavno možgansko kapjo zaradi možganske krvavitve.
The safety and efficacy of prophylactic doses in obese patients (BMI > 30 kg/m2) has not been fully determined and there is no consensus for dose adjustment.
Varnost in učinkovitost profilaktičnih odmerkov pri debelih bolnikih (ITM > 30 kg/m2) nista povsem ugotovljeni in soglasja glede prilagoditve odmerkov ni.
The subcutaneous injections of enoxaparin sodium were given until hospital discharge or for a maximum of eight days (whichever came first).
Subkutane injekcije natrijevega enoksaparinata so dobivali do odpusta iz bolnišnice ali največ osem dni (kar od tega je bilo prej).
Heparin aPTT Adjusted Intravenous Therapy n (%)
Heparinglede na aPTČ prilagojeno intravensko zdravljenje n (%)
What Inhixa is and what it is used for What you need to know before you use Inhixa How to use Inhixa
Kaj je zdravilo Inhixa in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Inhixa Kako uporabljati zdravilo Inhixa Možni neželeni učinki
- Other thrombolytics (e.g. alteplase, reteplase, streptokinase, tenecteplase, urokinase) and anticoagulants (see section 4.2).
- drugi trombolitiki (npr. alteplaza, reteplaza, streptokinaza, tenekteplaza, urokinaza) in antikoagulansi (glejte poglavje 4.2).
There were no significant differences in major haemorrhages, although a haemorrhage at the site of the subcutaneous injection was more frequent.
Značilnih razlik glede večjih krvavitev ni bilo, čeprav so bile krvavitve na mestu subkutane injekcije pogostejše.
• Your doctor will decide how long you should receive Inhixa.
• Zdravnik bo določil, koliko časa morate prejemati zdravilo Inhixa.
These are more likely to appear in the area you have been injected with Inhixa.
Verjetnost zanje je večja v predelih, kamor ste si injicirali zdravilo Inhixa.
This medicine should be injected just under the skin on your stomach, but not too near the belly button or any scar tissue (at least 5 cm away from these).
Zdravilo injicirajte samo pod kožo na trebuhu, vendar ne v bližini popka ali brazgotine (vsaj 5 cm stran).
Acute infective endocarditis
Akutni infekcijski endokarditis
Inhixa is a biosimilar medicinal product.
Inhixa je podobno biološko zdravilo.
Concomitant use with caution: The following medicinal products may be administered with caution concomitantly with enoxaparin sodium:
Sočasna uporaba, ki zahteva previdnost: Naslednja zdravila se lahko previdno uporabijo sočasno z natrijevim enoksaparinatom:
For continuous techniques, a similar delay of 24 hours should be observed before removing the catheter.
V primeru kontinuiranih tehnik je potreben podoben odlog 24 ur pred odstranitvijo katetra.
Benzyl alcohol may also cause toxic reactions in infants and children up to 3 years old, due to increased risk of accumulation (see section 4.4).
Benzilalkohol lahko povzroči tudi toksične reakcije pri dojenčkih in otrocih do 3 let, zaradi povečanega tveganja kopičenja (glejte poglavje 4.3).
If you use more Inhixa than you should
Če ste uporabili večji odmerek zdravila Inhixa, kot bi smeli
• you have endocarditis (an infection of the inner lining of the heart)
• če imate endokarditis (okužbo notranje plasti srčne stene)
The 3,000 IU (30 mg) dose can then be directly injected into the intravenous line.
Odmerek 3.000 i.e. (30 mg) lahko potem neposredno injicirate v intravensko linijo.
If a child accidentally injects or swallows Inhixa, take them to a hospital causualty department straight away.
Če si otrok po nesreči injicira ali zaužije zdravilo Inhixa, ga nemudoma peljite v bolnišnično ambulanto za nujno pomoč.
o For patients who undergo major orthopaedic surgery an extended thromboprophylaxis up to 5 weeks is recommended.
o Pri bolnikih z večjo ortopedsko operacijo je priporočljiva podaljšana tromboprofilaksa do 5 tednov.
• An initial dose of 3,000 IU (30 mg) of Inhixa will be given as injection into your vein.
• Začetni odmerek 3.000 i.e. (30 mg) zdravila Inhixa boste dobili kot injekcijo v veno.
Solution for injection in multidose vial 5 vials
Raztopina za injiciranje v večodmerni viali 5 vial
Inhixa can be used to:
Zdravilo Inhixa se uporablja za:
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
Obvestite svojega zdravnika ali farmacevta, če uporabljate ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
Do not use Inhixa
Ne uporabljajte zdravila Inhixa
Haemorrhage As with other anticoagulants, bleeding may occur at any site.
Krvavitev Tako kot pri drugih antikoagulansih se lahko kjer koli v telesu pojavi krvavitev.
The pharmacokinetic parameters of enoxaparin sodium have been studied primarily in terms of the time course of plasma anti-Xa activity and also by anti-IIa activity, at the recommended dosage ranges after single and repeated subcutaneous administration and after single intravenous administration.
Farmakokinetične parametre natrijevega enoksaparinata so raziskali predvsem, kar zadeva časovni potek plazemske aktivnosti anti-Xa, pa tudi aktivnosti anti-IIa, in sicer v priporočenih razponih odmerkov po enkratni in ponavljajoči se subkutani uporabi ter po enkratni intravenski uporabi.
VTE = Venous thromboembolic events which included DVT, PE, and death considered to be thromboembolic in origin * p value versus placebo = 0.0002
VTE = venski trombembolični dogodki; obsegali so GVT, PE in smrt, za katero je bilo ocenjeno, da je posledica trombembolije * Vrednost p v primerjavi s placebom = 0,0002
Moderate and mild renal impairment
Zmerna in blaga okvara ledvic
Arterial line injection
Injiciranje v arterijsko linijo
INSTRUCTIONS FOR USE: PRE-FILLED SYRINGE
NAVODILA ZA UPORABO: NAPOLNJENA INJEKCIJSKA BRIZGA
The safety and efficacy of enoxaparin sodium in children have not been established (see section 4.2).
Varnost in učinkovitost natrijevega enoksaparinata pri otrocih nista ugotovljeni (glejte poglavje 4.2).
Inhixa should not be used interchangeably with other medicines belonging to the group of low molecular weight heparins.
Zdravila Inhixa se ne sme uporabljati medsebojno zamenljivo z drugimi zdravili iz skupine nizkomolekularnih heparinov.
Enoxaparin sodium is administered by deep subcutaneous injection.
Natrijev enoksaparinat se daje z globoko subkutano injekcijo.
Enoxaparin sodium is primarily metabolized in the liver by desulfation and/or depolymerisation to lower molecular weight species with much reduced biological potency.
Natrijev enoksaparinat se presnovi predvsem v jetrih z desulfuracijo in/ali depolimerizacijo v vrste z manjšo molekulsko maso in veliko manjšo biološko močjo.
Other medicines and Inhixa Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
Druga zdravila in zdravilo Inhixa Obvestite svojega zdravnika ali farmacevta, če uporabljate ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
Signs of an allergic reaction include: rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue - if you are allergic to heparin or other low molecular weight heparins such as nadroparin, tinzaparin or dalteparin - if you have had a reaction to heparin that caused a severe drop in the number of your clotting cells (platelets) - this reaction is called heparin-induced thrombocytopenia - within the last 100 days or if you have antibodies against enoxaparin in your blood - if you are bleeding heavily or have a condition with a high risk of bleeding (such as stomach ulcer, recent surgery of the brain or eyes), including recent bleeding stroke - if you are using Inhixa to treat blood clots in your body and going to receive spinal or epidural anaesthesia or lumbar puncture within 24 hours - if the patient is a premature or newborn baby up to 1 month because of the risk of severe toxicity including abnormal respiration (“gasping syndrome”).
Med znaki alergijske reakcije so: izpuščaj, težave s požiranjem ali dihanjem, oteklost ustnic, obraza, žrela ali jezika; - če ste alergični na heparin ali druge nizkomolekularne heparine, npr. na nadroparin, tinzaparin ali dalteparin; - če ste imeli v zadnjih 100 dneh reakcijo na heparin, ki je povzročila hudo zmanjšanje števila trombocitov (krvnih ploščic) - takšno reakcijo imenujemo s heparinom izzvana trombocitopenija - ali če imate v krvi protitelesa proti enoksaparinu; - če močno krvavite ali imate kakšno motnjo, ki jo spremlja veliko tveganje za krvavitev (npr. razjedo na želodcu, nedavno operacijo na možganih ali očeh), vključno z nedavno možgansko kapjo zaradi možganske krvavitve; - če uporabljate Inhixa za zdravljenje krvnih strdkov in imate v 24 urah predvideno spinalno anestezijo, epiduralno anestezijo ali lumbalno punkcijo; - če je pacient novorojenček ali prezgodaj rojen novorojenček do 1 meseca starosti zaradi tveganja za hudo toksičnost, vključno z nenormalnim dihanjem ("sindrom hlastanja za zrakom").
You will be given 2,000 IU (20 mg) or 4,000 IU (40 mg) of Inhixa each day.
Dobili boste 2.000 i.e. (20 mg) ali 4.000 i.e. (40 mg) zdravila Inhixa na dan.
• Your doctor or nurse will normally give you Inhixa.
• Običajno vam bo zdravilo Inhixa dal zdravnik ali medicinska sestra.
Pack-sizes of 1 or 5 vials containing 10 mL.
Pakiranja s 1 ali 5 vialami, ki vsebujejo 10 ml.
All Treated Medical Patients During Acute Illness
Vsi zdravljeni nekirurški bolniki med akutno boleznijo
Insert the full length of the needle into the skin fold.
Celotno dolžino igle zabodite v kožno gubo.
However, your doctor may give you a further dose of 50 IU to 100 IU (0.5 to 1 mg) for every kilogram of your weight, if necessary.
Vendar vam zdravnik lahko da dodaten odmerek od 50 do 100 i.e. (0,5 do 1 mg) na kilogram telesne mase, če je to potrebno.
Do not mix with other medicinal products.
Zdravila ne smete mešati z drugimi zdravili.
• Inhixa is usually given by injection underneath the skin (subcutaneous).
• Zdravilo Inhixa se po navadi injicira pod kožo (subkutano).
Enoxaparin sodium is to be used with extreme caution in patients with a history (> 100 days) of heparin-induced thrombocytopenia without circulating antibodies.
Natrijev enoksaparinat je treba skrajno previdno uporabljati pri bolnikih z anamnezo (> 100 dni) heparinsko izzvane trombocitopenije brez protiteles v obtoku.
Pack-sizes of 1 vial containing 3 mL.
Pakiranja z 1 vialo, ki vsebuje 3 ml.
The safety and efficacy of enoxaparin sodium in paediatric population have not been established.
Varnost in učinkovitost natrijevega enoksaparinata pri pediatrični populaciji nista ugotovljeni.
The contents of the bag should be gently mixed.
Vsebino vrečke nežno premešajte.
Patients received enoxaparin sodium (4,000 IU (40 mg) subcutaneously) daily for 6 to 10 days and were then randomly assigned to receive either enoxaparin sodium or placebo for another 21 days.
Bolniki so prejemali natrijev enoksaparinat (4.000 i.e. (40 mg) subkutano) na dan od 6 do 10 dni, potem pa so bili randomizirani na prejemanje natrijevega enoksaparinata ali placeba za nadaljnjih 21 dni.
Pre-filled syringe 3 years
Napolnjena injekcijska brizga 3 leti
See section “Do not use Inhixa”.
Glejte tudi poglavje "Ne uporabljajte zdravila Inhixa".